Publication:
Chemoprevention of cancer: current evidence and future prospects

Thumbnail Image

Date

2015

Journal Title

Journal ISSN

Volume Title

Publisher

F1000Research
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Benetou, Vassiliki, Areti Lagiou, and Pagona Lagiou. 2015. “Chemoprevention of cancer: current evidence and future prospects.” F1000Research 4 (F1000 Faculty Rev): 916. doi:10.12688/f1000research.6684.1. http://dx.doi.org/10.12688/f1000research.6684.1.

Research Data

Abstract

Cancer chemoprevention refers to the use of agents for the inhibition, delay, or reversal of carcinogenesis before invasion. In the present review, agents examined in the context of cancer chemoprevention are classified in four major categories—hormonal, medications, diet-related agents, and vaccines—and the main representatives of each category are presented. Although there are serious constraints in the documentation of effectiveness of chemopreventive agents, mainly stemming from the long latency of the condition they are addressing and the frequent lack of intermediate biomarkers, there is little disagreement about the role of aspirin, whereas a diet rich in vegetables and fruits appears to convey more protection than individual micronutrients. Among categories of cancer chemopreventive agents, hormonal ones and vaccines might hold more promise for the future. Also, the identification of individuals who would benefit most from chemopreventive interventions on the basis of their genetic profiles could open new prospects for cancer chemoprevention.

Description

Keywords

Articles, Breast Diseases: Benign & Malignant, Cancer Therapeutics, Clinical Nutrition, Diabetes & Obesity, Endocrine & Metabolic Pharmacology, Gastrointestinal Cancers, Genitourinary Cancers, Immunopharmacology & Hematologic Pharmacology, Menopause & Post-Reproductive Women's Health, Preventive Medicine, Toxicology, Cancer, chemoprevention, aspirin, nutrients, supplements, antiestrogens, antiandrogens, SERMs, aromatase inhibitors, vaccines, HBV, HPV

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Referenced By

Related Stories